Sources indicate that Silgan is working with advisers on a proposal that may value Gerresheimer at €41 per share.

MUNICH, March 20 (Reuters) - U.S. packaging company Silgan Holdings has signalled interest in taking over German medical ...

Gerresheimer AG's (ETR:GXI) earnings announcement last week didn't impress shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive ...

If you want to know who really controls Gerresheimer AG (FRA:GXI), then you’ll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect ...

BERLIN (Reuters) -Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations.

(Reuters) -German packaging and medical equipment maker Gerresheimer expects diabetes and diet drugs to contribute 350 million euros ($376 million) of annual revenue by the 2026/27 financial year, CFO ...

(RTTNews) - Shares of Gerresheimer AG (GRRMF.PK) were losing around 16 percent in the mid-day trading in Germany after the manufacturer of primary packaging products for medication and drug delivery ...

Gerresheimer AG's (ETR:GXI) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern. Our ...

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership.

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of ...